Cardano and the Value of Patient Data

Florian Krüger-Herbert outlined a healthcare data marketplace in which patients could choose which information to share, approve its intended use, and participate in the revenue it generates. The discussion appeared in a Let’s Talk Cardano episode published on October 2, 2026, and recorded at Cardano Summit 2025, when he led innovation and venture building for EMEA at Johnson & Johnson Innovative Medicine. Cardano entered the conversation through transparent payment records, data integrity, and authentication of digital services.

Patient Control and Healthcare Data Markets

Krüger-Herbert’s experience spans pharmaceutical distribution, a digital health startup, Philips, and Johnson & Johnson. His projects have included electronic health records, medical wearables, telemedicine, and digital surgery systems that analyze operation footage to support surgical training.

Privacy questions followed that work from the beginning. An early medication reminder, initially developed as a Facebook application, prompted users to ask what happened to their information. The team subsequently moved the service outside the platform. Later projects brought questions about hosting locations, access permissions, and international cloud providers.

Smartwatches, rings, and health applications made continuous data collection more familiar. In his assessment, interest in control is returning as people recognize that their information supports business models beyond the functions they receive.

Access remains fragmented. Records sit across hospitals, physicians, laboratories, and commercial applications, while patients face difficulties combining them. He cited exporting wearable information for personal analysis as one practical obstacle.

The marketplace concept would bring laboratory results, biomarkers, genetic information, and wearable records into a patient-controlled environment. Individuals could authorize selected information for scientific research, pharmaceutical development, or AI diagnostic systems and receive compensation for that access.

Researchers and companies could request datasets matching specific criteria, such as sex, geography, or particular biomarkers. People meeting those requirements would decide whether to participate.

That arrangement would give patients a separate decision about secondary data use, beyond the sharing required for their treatment. Krüger-Herbert distinguished it from hospital systems that consolidate documentation while retaining organizational control over its management.

Payment also introduces a consent question. The host challenged whether financial incentives could encourage people to disclose information they would otherwise keep private and later regret sharing.

Krüger-Herbert argued that choice and compensation could improve the position of people already contributing information to digital services. He acknowledged that previously distributed data creates a separate problem. The discussion left withdrawal of consent and deletion of existing copies unresolved.

Cardano for Payments, Records, and Agent Identity

Reef Data provided a concrete comparison. The Hamburg data cooperative allows individuals to request information from companies and decide what to contribute to a shared pool.

According to the Cardano Foundation’s case study, its application converts raw files into a more understandable format. Information selected for sharing is anonymized on the user’s device before business partners negotiate access with the cooperative.

Reef Data uses Reeve, the Foundation’s open-source financial reporting platform, to record transactions and rewards on Cardano. Members and auditors can independently check financial flows. Krüger-Herbert referenced this broader personal-data approach when considering a comparable healthcare model.

A medical implementation would also need to make gathering records straightforward. Repeatedly downloading and uploading files from separate providers would create friction before a patient could make any sharing decision.

Laboratory reports supplied another potential application. Blockchain could support checking whether a document had changed after its issuance and as it moved between authorized recipients. That function concerns record integrity; laboratory quality and clinical interpretation remain responsibilities of the professionals performing those activities.

The public nature of blockchain also requires deliberate privacy choices. The discussion addressed the need to distinguish verifiable records from sensitive information that must remain confidential.

AI agents introduce a related identity problem. As assistants communicate with users and perform automated tasks, people need to establish whether an agent genuinely represents its claimed organization.

Krüger-Herbert considered a hospital assistant providing information before an appointment or guiding someone through administrative procedures. Blockchain could potentially support authentication of that agent and its organizational affiliation.

He expects this infrastructure to remain largely invisible to patients. A healthcare service would be selected for its usefulness, accessibility, and reliability, with the underlying technology supporting those functions.

Medical AI and Accountability

Projects Krüger-Herbert followed in the United Arab Emirates included biomarker tracking, longevity research, and gut microbiome analysis. He highlighted services connecting home sample collection with laboratory processing and digital access to results.

One microbiome platform combined a home test with an AI interface for questions about the findings. According to figures he cited during the recording, simplifying the process reduced the service’s price from approximately 4,000 to 2,000 dirhams.

A separate physician interface condensed a report of roughly 120 pages into around a page and a half of medically structured information. The original document remained available for review.

He positioned the tools as preparation for a consultation. Patients could ask preliminary questions, while physicians received a summary before discussing the results. Clinical assessment and treatment decisions would remain with the doctor.

Accountability became a central part of that exchange. A persuasive AI answer can appear reliable while misinterpreting information or relying on flawed sources. Scientific references alone do not establish that its conclusions are sound.

Krüger-Herbert described an approach in which laboratories perform the analysis and generate reports, while AI produces explanations from existing information and selected guidelines. He emphasized the involvement of physicians and researchers, the comparison datasets, and how the system was developed.

The participants also considered tracing how AI outputs were produced. That raised a further question about how deeply verification would need to extend into training material and the research papers behind it.

Regulation formed part of the discussion through the European Health Data Space. Its regulation, published in March 2025, establishes a framework for access to electronic health information, exchange, and permitted reuse, with implementation proceeding in stages.

Krüger-Herbert described healthcare as a shared environment involving hospitals, laboratories, insurers, manufacturers, and regulators, each with different permissions and responsibilities. Trust therefore extends beyond the relationship between a patient and a single application.

At the summit’s hackathon, he had participated in a healthcare prototype linking a data workflow with blockchain. For a laboratory report, he identified a specific use: verifying that, since leaving the laboratory, it “has not been manipulated, faked or touched.” That proposed check would accompany the document as other services reuse it.